HealthDay.com
Access to High-Cost Targeted Treatments Varies for Lung Cancer
Patients treated at a National Cancer Institute-designated center more likely to receive these drugs for lung cancer
Single Antidepressant Dose of Intravenous Ketamine Safe
No serious, long-lasting side effects seen for treatment of resistant depression
Non-HDL Cholesterol Levels Linked to Long-Term ASCVD Risk
Fifty percent reduction in non-HDLC concentration linked to reduced risk for CVD event by age 75 years
One in Three Parents Report Skipping Doctor, Dentist Appointment
Parents unaware of impact socioeconomic factors can have on chronic disease
SABCS: Long-Term Outcomes Good for PBI in Early Breast Cancer
10-year ipsilateral breast tumor recurrence rates similar for partial, whole breast irradiation
Insurance Disparities ID’d in Diagnosis of Late-Stage Melanoma
Odds of late-stage melanoma up for individuals with Medicaid, no insurance versus those with private insurance
Shortage of Applied Behavior Analysts Found for Children With Autism
Supply of ABA providers falls short of benchmark for 49 states and Washington, D.C.
Stroke Risk Up With Long Sleep Duration, Long Midday Napping
Also, risks for total, ischemic, hemorrhagic stroke increased with poor versus good sleep quality
2003 to 2017 Saw Increase in Deaths at Home, Hospice Facility
Greatest odds of death at home and at hospice facility seen for patients with cancer
SABCS: Addition of Tucatinib Ups Survival in HER2+ Metastatic Breast Cancer
In heavily pretreated patients, adding tucatinib versus placebo improves overall, progression-free survival
